Citation: | ZHOU Li, PAN Yandong, JIANG Huiyi, PANG Zengyuan, YE Minyi. Clinical study on detoxification of radiotherapy for recurrent nasopharyngeal carcinoma by syndrome differentiation and treatment of traditional Chinese medicine[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 93-95. DOI: 10.7619/jcmp.20211777 |
[1] |
YANG K, TIAN J, ZHANG B, et al. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with loco regionally advanced nasopharyngeal carcinoma[J]. Oral Oncol, 2019, 98: 85-91. doi: 10.1016/j.oraloncology.2019.09.022
|
[2] |
ZHOU E H, ZHANG W J, LI H J, et al. Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups[J]. Eur Radiol, 2019, 29: 5590-5599. doi: 10.1007/s00330-019-06075-1
|
[3] |
刘诗雅, 朱道琦, 杨家彬, 等. 生脉注射液对人鼻咽癌CNE-2细胞抗拒株的放射增敏作用[J]. 世界科学技术-中医药现代化, 2020, 22(3): 804-809. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202003042.htm
|
[4] |
刘畅, 郑荣华, 温武, 等. 白花蛇舌草水提物对鼻咽癌细胞放疗增敏的作用及其机制[J]. 山西医科大学学报, 2020, 51(3): 219-223. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYX202003006.htm
|
[5] |
SHIMADA M, ITAMOCHI H, KIGAWA J. Nedaplatin: a Cisplatin derivative in cancer chemotherapy[J]. Cancer Manag Res, 2013, 8(5): 67-76. http://pubmedcentralcanada.ca/pmcc/articles/PMC3658440/
|
[6] |
PIRES AMT, SEGRETO RA, SEGRETO HRC. RTOG criteria to evaluate acute shin reaction and its risk factors in patients with breast cancer submitted to radiotherapy[J]. Rev Lat Am Enfermagem, 2008, 16(7): 844-849. http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0104-11692008000500008&lng=en&nrm=iso&tlng=en
|
[7] |
COLEVAS A D, YOM S S, PFISTER D G, et al. NCCN guidelines insights: head and neck cancers, version 1, 2018[J]. J Natl Compr Canc Netwo, 2018, 16(5): 479-490. doi: 10.6004/jnccn.2018.0026
|
[8] |
AHAMD P, SANA J, SLAVIK M, et al. MicroRNAs involvement in radio resistance of head and neck cancer[J]. Dis Markers, 2017, 82(4): 53-55. http://www.ncbi.nlm.nih.gov/pubmed/28325958
|
[9] |
艾茹玉, 周娟, 陈蓓, 等. 中医药防治鼻咽癌放疗后黏膜反应的研究现状[J]. 广州中医药大学学报, 2016, 33(3): 446-448. https://www.cnki.com.cn/Article/CJFDTOTAL-REST201603043.htm
|
[10] |
杨帆, 莫凯岚, 陈扬声. 鼻咽癌放疗前后中医证型分布及其演变规律的研究[J]. 广东药学院学报, 2014, 16(2): 238-238. doi: 10.3969/j.issn.1006-8783.2014.02.027
|
[11] |
赵为民, 刘林, 方法, 等. 黄芪注射液对Ⅲ期胃癌的疗效及对机体免疫功能的影响[J]. 世界中医药, 2016, 11(6): 982-985. doi: 10.3969/j.issn.1673-7202.2016.06.011
|
[12] |
林冯杰, 徐鹭英. 参麦注射液防治局部晚期鼻咽癌放疗不良反应40例临床观察[J]. 中医药导报, 2014, 20(16): 39-40. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201416016.htm
|
1. |
赵蕾,魏岚,费晓璐. 血糖间隙对药物保守治疗脑卒中患者症状性颅内出血的预测价值. 国际老年医学杂志. 2024(04): 414-418 .
![]() | |
2. |
廖青玲. 血清CK-MB、MYO、cTnI、NT-proBNP联合检测在急性心肌梗死早期诊断中应用价值. 黑龙江医学. 2024(15): 1844-1846 .
![]() | |
3. |
韩佳玉,徐明星. 基于循证理念的延续护理对老年心血管疾病患者介入术后再发主要心血管不良事件的影响. 中国医药导报. 2023(10): 170-173+193 .
![]() | |
4. |
刘亚楠,张逸,吴慧. 司美格鲁肽对2型糖尿病患者心血管危险因素的影响. 糖尿病新世界. 2023(10): 73-76 .
![]() | |
5. |
张俊峰,苏绍红. 急性心肌梗死主要不良心血管事件的血清指标预测研究. 实用临床医药杂志. 2023(23): 31-36+42 .
![]() |